Wangyu Zhu
Overview
Explore the profile of Wangyu Zhu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
583
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Huang X, Xiao S, Zhu X, Yu Y, Cao M, Zhang X, et al.
Cell Death Dis
. 2020 Sep;
11(9):785.
PMID: 32963220
Our recent study demonstrated that the QKI-5 regulated miRNA, miR-196b-5p, and it functions as an onco-microRNA in non-small cell lung cancer (NSCLC) by directly targeting GATA6 and TSPAN12. However, the...
12.
Liang G, Meng W, Huang X, Zhu W, Yin C, Wang C, et al.
Proc Natl Acad Sci U S A
. 2020 Feb;
117(8):4347-4357.
PMID: 32041891
Lung cancer is the leading cause of cancer-related deaths worldwide and non-small cell lung cancer (NSCLC) accounts for over 80% of lung cancer cases. The RNA binding protein, QKI, belongs...
13.
Zhao J, Wang J, Dang J, Zhu W, Chen Y, Zhang X, et al.
Stem Cell Res Ther
. 2019 Jun;
10(1):165.
PMID: 31196163
Background: Mounting evidence has shown that a novel subset of mesenchymal stem cells (MSCs) derived from human gingiva referred to as gingival mesenchymal stem cells (GMSCs) displays a greater immunotherapeutic...
14.
Yin C, Dai X, Huang X, Zhu W, Chen X, Zhou Q, et al.
J Cell Mol Med
. 2019 Jan;
23(3):2194-2206.
PMID: 30609207
Triple-negative breast cancer (TNBC) is a subtype of breast cancer with poor clinical outcome and currently no effective targeted therapies are available. Alantolactone (ATL), a sesquiterpene lactone, has been shown...
15.
Le H, Wang X, Zha Y, Wang J, Zhu W, Ye Z, et al.
Oncol Lett
. 2017 Dec;
14(6):7931-7940.
PMID: 29250182
Lung adenocarcinoma, characterized by its early and aggressive local invasion and high metastatic potential, is the most frequently observed histological type of non-small-cell lung cancer (NSCLC). Visceral pleural invasion (VPI)...
16.
Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H, et al.
PLoS One
. 2016 Apr;
11(4):e0153046.
PMID: 27093275
Blood-circulating miRNAs could be useful as a biomarker to detect lung cancer early. We investigated the serum levels of four different miRNAs in patients with non-small cell lung cancer (NSCLC)...
17.
Xu L, Huang Y, Chen D, He J, Zhu W, Zhang Y, et al.
Cancer Genet
. 2014 Jun;
207(5):214-20.
PMID: 24906642
Recent studies have shown that plasma miR-21 is a biomarker of chemotherapeutic response in lung cancer, but the influence of miR-21 on the sensitivity of non-small-cell lung cancer (NSCLC) to...
18.
Zhu W, He J, Chen D, Zhang B, Xu L, Ma H, et al.
PLoS One
. 2014 Feb;
9(2):e87780.
PMID: 24523873
Background: Altered expression of miRNA expression contributes to human carcinogenesis. This study was designed to detect aberrant miRNA expressions as a potential biomarker for early detection and prognosis prediction of...
19.
Ma H, Cai H, Zhang Y, Wu J, Liu X, Zuo J, et al.
Cancer Lett
. 2014 Feb;
344(1):74-81.
PMID: 24513266
Membrane associated guanylate kinase (MAGUK) family, has been extensively studied in cellular adhesion and signal transduction at sites of cell–cell contact. Recently, growing attention has been paid to its role...
20.
Chen C, Chen D, Zhang Y, Chen Z, Zhu W, Zhang B, et al.
Int Immunopharmacol
. 2013 Dec;
18(2):255-61.
PMID: 24345703
Little is known about the regulatory T cells (Tregs) in the peripheral blood after surgery of non-small cell lung cancer (NSCLC) patients. In this study, we investigated whether CD4+CD25+FOXP3+ and...